Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P154. First diagnostic endoscopy does not predict disease course except stenosis, while smoking predisposes patients to severe endoscopic relapse in Crohn's disease
P154. Risk factors for colectomy and pouchitis in ulcerative colitis patients with severe flare-up
Authors:

K. Farkas1, F. Nagy1, Z. Szepes1, A. Bálint1, T. Nyári2, T. Wittmann1, T. Molnár1, 1University of Szeged, First Department of Medicine, Szeged, Hungary, 2University of Szeged, Department of Medical Informatics, Szeged, Hungary

P154. Tolerability and safety of conventional thiopurines concomitantly with allopurinol in IBD-patients with a skewed thiopurine metabolism
P154

Identifying predictors of low adherence in patients with Inflammatory Bowel Disease

Authors:

S. Coenen1, E. Weyts*1, V. Ballet1, M. Noman1, G. Van Assche1, S. Vermeire1, J. Vanemelen2, M. Ferrante1

1UZ Leuven, Gastroenterology, Leuven, Belgium, 2MACX , Integrated Care, Aartselaar, Belgium

P155.

Quality Improvement Tool: 3 year outcome

Authors:

S. Chadokufa1, B. Huggett1, F. Kiparissi2, V. Evans2, K. Lindley2, N. Shah2, M. Mamoun Elawad2, N. Acton2, 1Great Ormond Street Hospital, Paediatric Gastroenterology, London, United Kingdom, 2Great Ormond Street Hospital, Gastro, London, United Kingdom

P155. In-vitro dissolution testing of 5-aminosalicylic acid release from pH dependent mesalazine formulations
P155. Relationship between weight, body mass index and bone mineral density in inactive inflammatory bowel disease patients under 50 years old
Authors:

W. Moon1, T.O. Kim2, S.J. Park1, M.I. Park1, H.H. Kim1, 1Kosin University, Department of Internal Medicine, Busan, South Korea, 2Inje University, Department of Internal Medicine, Busan, South Korea

P155. Vitamin D status in inflammatory bowel disease: Are clinicians seeing the light?
P155

Comparison of video capsule endoscopy and faecal calprotectin as diagnostic tools in patients with abdominal symptoms suggestive of small bowel Crohn's Disease

Authors:

K.V. Patel*, S. Zaman, S. Fong, S.H. Anderson

Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, United Kingdom

P156.

Pulmonary involvement in IBD patients and the effect of TNF-alpha inhibitors on pulmonary function

Authors:

J. Bethge1, M. Ellrichmann1, C. Conrad1, S. Nikolaus1, R. Noth2, D. Schuldt1, S. Zeissig1, S. Schreiber1,2, 1University Medical Center, Schleswig Holstein, Campus Kiel, Medical Department I, Gastroenterology, Kiel, Germany, 2University Medical Center Schleswig Holstein, Campus Kiel, Medical Department I, Pneumology, Kiel, Germany

P156. Development of quality standards for the management of inflammatory bowel disease by nurses: Perspectives of professionals and patients
P156. Quality of life, anxiety and depression in patients with inflammatory bowel diseases depend of extraintestinal manifestations
P156. Reduction in colectomy- and health care-related costs in ulcerative colitis patients treated with adalimumab compared with standard therapy
Authors:

M. Chiorean1, M. Yang2, J. Rizzo2, J. Chao2, P.M. Mulani2, 1Virginia Mason Medical Center, Seattle, WA, United States, 2Abbott Laboratories, Abbott Park, IL, United States

P156

Comparison of fetal risks in pregnancy before and after diagnosis of Inflammatory Bowel Disease: A prospective study

Authors:

L. Kecili*, N. Bounab, N. Kaddache, K. Layaida, T. Boucekkine, N. Debzi, S. Berkane

CHU Mustapha, Gastroenterology, Alger, Algeria

P157.

Proximal disease extension and related predicting factors in ulcerative proctitis

Authors:

B. Kim, S.J. Park, S.P. Hong, T.I. Kim, W.H. Kim, J.H. Cheon, Yonsei University College of Medicine, Department of Internal Medicine and Institute of Gastroenterology, Seoul, South Korea

P157. Improvement in hematological status and symptoms in IBD patients using ferric carboxymaltose (Ferinject®): A German multicenter non-interventional study
P157. Reasons for a delayed diagnosis in inflammatory bowel disease
Authors:

A. Degen1, C. Büning2, B. Siegmund3, M. Prager2, J. Maul3, J. Preiß3, B. Wiedenmann1, A. Sturm4, A. Schirbel1, 1Charite Campus Virchow Klinikum, Germany, 2Charite Campus Mitte, Germany, 3Charite Campus Benjamin Franklin, Germany, 4Waldfriede Krankenhaus, Germany

P157. The clinical efficacy of novel tag-less Agile Patency Capsule (Agile‑J) for Crohn's disease patients with suspected or known intestinal stricture prior to capsule endoscopy procedure, a prospective, open-label study
P157

A randomised, assessor-blinded, multicentre trial (OPTIMA) investigating the efficacy, safety and tolerability of a novel tailored split-dosing schedule for colon cleansing in preparation for colonoscopy

Authors:

R. Kiesslich*1, C. Angelin2, M. Stoltenberg3, A. Falahati4, J. Masure5

1Dr. Horst Schmidt Clinic, Department of Gastroenterology, Wiesbaden, Germany, 2Ferring Pharmaceuticals A/S, International PharmaScience Center, Clinical Operations, Copenhagen, Denmark, 3Ferring Pharmaceuticals A/S, International PharmaScience Center, Clinical R&D Gastroenterology, Copenhagen, Denmark, 4Ferring Pharmaceuticals A/S, International PharmaScience Center, Global Biometrics, Copenhagen, Denmark, 5Ferring International Center SA, Gastroenterology & Endocrinology, St Prex, Switzerland

P158.

Prospective comparison of magnetic resonance imaging, rectal and perineal ultrasound and the surgical findings of complicated perianal Crohn's disease: a new kid on the block

Authors:

R. Bor1, A. Bálint1, K. Farkas1, M. Szucs2, Z. Szepes1, T. Wittmann1, F. Nagy1, T. Molnar1, 1University of Szeged, First Department of Medicine, Szeged, Hungary, 2University of Szeged, Department of Medical Physics and Informatics, Szeged, Hungary